98%
921
2 minutes
20
Purpose: To compare the potential effectiveness and safety of non-Descemet stripping endothelial keratoplasty (nDSEK) and Descemet stripping endothelial keratoplasty (DSEK) in treating endothelial decompensation.
Methods: A retrospective comparative analysis was conducted on patients with endothelial decompensation who underwent either nDSEK or DSEK procedures between August 2017 and January 2024. Participants were observed for a minimum duration of 12 months. The study documented key variables like best corrected visual acuity (BCVA), endothelial cell density (ECD), endothelial cell loss (ECL), and any issues that occurred during the follow-up period.
Results: A total of 85 eyes from 85patients (nDSEK = 40 eyes, DSEK = 45 eyes) were ultimately included in the study for analysis based on the inclusion and exclusion criteria. The mean BCVA (logMAR) showed significant improvement from the preoperative measurement of 1.66 ± 0.26 to 0.37 ± 0.11 in nDSEK eyes and from the preoperative 1.68 ± 0.24 to 0.36 ± 0.10 in DSEK eyes, respectively, at postoperative 12 months. However, there was no statistically significant difference in the improvement of BCVA between the nDSEK and DSEK eyes ( = 0.605). The mean donor ECD decreased from the preoperative 2,814 ± 85 cells/mm to 1,195 ± 216 cells/mm (ECL 57.5%) in nDSEK eyes and from the preoperative 2,889 ± 125 cells/mm to 1,266 ± 285 cells/mm (ECL 56.2%) in DSEK eyes, respectively, at postoperative 12 months, with no significant difference between the nDSEK and DSEK eyes ( = 0.192). The occurrence of various complications (e.g., graft dislocation, acute hypertension, primary graft failure, graft rejection) was comparable between nDSEK and DSEK eyes.
Conclusion: nDSEK eliminated the descemetorhexis step but yielded a comparable clinical outcome in effectiveness and safety compared to DSEK for treating endothelial decompensation.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12129991 | PMC |
http://dx.doi.org/10.3389/fmed.2025.1499422 | DOI Listing |
J Cataract Refract Surg
September 2025
Department of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor, MI, USA.
Purpose: To evaluate whether primary graft failure (PGF) rates and endothelial cell loss (ECL) differ between surgeon-trephined/loaded and eye bank-preloaded Descemet stripping automated endothelial keratoplasty (DSAEK) grafts.
Setting: Tertiary care academic center.
Design: Retrospective case series and ex vivo laboratory study.
Cell Tissue Bank
September 2025
Department of Ophthalmology and Visual Sciences, McGill University, Montreal, Canada.
To summarize the evidence examining the outcomes of Descemet membrane endothelial keratoplasty (DMEK) using eye bank pre-stripped versus surgeon prepared grafts. Systematic review and meta-analysis. This study was conducted following the preferred reporting items for systematic reviews and meta-analyses consensus statement (PROSPERO ID: CRD42023457120).
View Article and Find Full Text PDFCornea
September 2025
Department of Ophthalmology, Tokyo Dental College Ichikawa General Hospital, Chiba, Japan.
Purpose: To investigate the association between preoperative aqueous humor (AqH) cytokines and mid-term endothelial cell density (ECD) after Descemet stripping automated endothelial keratoplasty (DSAEK).
Methods: This prospective study included 80 eyes: 47 eyes undergoing DSAEK and 33 cataract surgery eyes as controls. AqH samples were collected at the beginning of surgery.
Cornea
September 2025
Department of Translational Medicine, University of Ferrara, Ferrara, Italy.
Purpose: To describe the surgical technique for 2-piece mushroom penetrating keratoplasty using the "pull-through" technique in infant eyes.
Methods: Using a 250-μm microkeratome head, the donor cornea was split into anterior and posterior lamella, which were then punched to 8.0 to 8.
Cornea
September 2025
Cataract and Refractive Services, The Shantilal Shanghvi Cornea Institute, Hyderabad, Telangana, India; and.
Purpose: To analyze the outcomes of phacoemulsification with intraocular lens (IOL) implantation in patients with Axenfeld-Rieger syndrome (ARS).
Methods: This was a retrospective observational study. Patients with ARS who underwent cataract surgery and had a minimum postoperative follow-up of 6 weeks were included.